The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abivax SA - ADR | SPONSORED ADS | 00370M103 | 26,672,668 | 239,539 | SH | SOLE | 239,539 | 0 | 0 | |||
| Aclaris Therapeutics, Inc. | Common | 00461U105 | 24,999,998 | 6,666,666 | SH | SOLE | 6,666,666 | 0 | 0 | |||
| Alto Neuroscience Inc | Common | 02157Q109 | 23,279,186 | 1,035,551 | SH | SOLE | 1,035,551 | 0 | 0 | |||
| ALX Oncology Holdings Inc | Common | 00166B105 | 6,385,350 | 3,184,713 | SH | SOLE | 3,184,713 | 0 | 0 | |||
| AN2 Therapeutics Inc | Common | 037326105 | 10,785,449 | 3,153,640 | SH | SOLE | 3,153,640 | 0 | 0 | |||
| Arrivent BioPharma Inc | Common | 04272N102 | 20,438,082 | 885,916 | SH | SOLE | 885,916 | 0 | 0 | |||
| Bolt Therapeutics Inc | Common | 097702203 | 292,553 | 72,414 | SH | SOLE | 72,414 | 0 | 0 | |||
| Bright Minds Biosciences Inc | Common | 10919W405 | 40,656,841 | 557,172 | SH | SOLE | 557,172 | 0 | 0 | |||
| CAMP4 Therapeutics Inc | Common | 13463J101 | 18,727,365 | 4,246,568 | SH | SOLE | 4,246,568 | 0 | 0 | |||
| Cogent Biosciences Inc | Common | 19240Q201 | 16,254,327 | 422,300 | SH | SOLE | 422,300 | 0 | 0 | |||
| Compass Pathway PLC | SPONSORED ADS | 20451W101 | 1,106,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| Compass Therapeutics Inc | Common | 20454B104 | 50,495,515 | 9,545,466 | SH | SOLE | 9,545,466 | 0 | 0 | |||
| Corvus Pharmaceuticals Holdings | Common | 221015100 | 41,049,088 | 2,805,816 | SH | SOLE | 2,805,816 | 0 | 0 | |||
| DBV Technologies SA | SPONSORED ADS | 23306J309 | 55,725,516 | 2,667,569 | SH | SOLE | 2,667,569 | 0 | 0 | |||
| Design Therapeutics Inc | Common | 25056L103 | 17,161,288 | 1,612,903 | SH | SOLE | 1,612,903 | 0 | 0 | |||
| Dianthus Therapeutics Inc | Common | 252828108 | 29,707,512 | 353,998 | SH | SOLE | 353,998 | 0 | 0 | |||
| Dyne Therapeutics Inc | Common | 26818M108 | 28,236,859 | 1,557,466 | SH | SOLE | 1,557,466 | 0 | 0 | |||
| Erasca Inc | Common | 29479A108 | 196,610,946 | 12,151,480 | SH | SOLE | 12,151,480 | 0 | 0 | |||
| Eupraxia Pharmaceuticals Inc | Common | 29842P105 | 9,774,000 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | |||
| Geron Corp | Common | 374163103 | 12,920,978 | 8,671,797 | SH | SOLE | 8,671,797 | 0 | 0 | |||
| Instil Bio Inc | Common | 45783C200 | 2,412,202 | 292,743 | SH | SOLE | 292,743 | 0 | 0 | |||
| LB Pharmaceuticals Inc | Common | 50180M108 | 19,728,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
| Minerva Neurosciences Inc | Common | 603380205 | 26,044,551 | 4,322,747 | SH | SOLE | 4,322,747 | 0 | 0 | |||
| Monopar Therapeutics Inc | Common | 61023L207 | 4,958,495 | 90,500 | SH | SOLE | 90,500 | 0 | 0 | |||
| Moonlake Immunotherapeutics | Common | 61559X104 | 18,640,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| Olema Pharmaceuticals Inc | Common | 68062P106 | 10,017,179 | 671,843 | SH | SOLE | 671,843 | 0 | 0 | |||
| Onkure Therapeutics Inc | Common | 68277Q105 | 7,980,719 | 1,927,710 | SH | SOLE | 1,927,710 | 0 | 0 | |||
| Oric Pharmaceuticals Inc | Common | 68622P109 | 23,424,119 | 1,848,786 | SH | SOLE | 1,848,786 | 0 | 0 | |||
| Pasithea Therapeutics Corp | Common | 70261F202 | 1,557,780 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | |||
| Pepgen Inc | Common | 713317105 | 4,115,250 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | |||
| Praxis Precision Medicines | Common | 74006W207 | 109,188,580 | 338,895 | SH | SOLE | 338,895 | 0 | 0 | |||
| Precision Biosciences Inc | Common | 74019P207 | 25,713 | 4,675 | SH | SOLE | 4,675 | 0 | 0 | |||
| SAB Biotherapeutics Inc | Common | 78397T202 | 43,738,600 | 11,420,000 | SH | SOLE | 11,420,000 | 0 | 0 | |||
| Satellos Bioscience Inc | Common | 80401L803 | 4,580,940 | 813,666 | SH | SOLE | 813,666 | 0 | 0 | |||
| Sensei Biotherapeutics Inc | Common | 81728A207 | 22,758,070 | 722,020 | SH | SOLE | 722,020 | 0 | 0 | |||
| Sera Prognostics Inc | Common | 81749D107 | 3,350,393 | 1,650,440 | SH | SOLE | 1,650,440 | 0 | 0 | |||
| Sinovac Biotech Ltd. | SHS | P8696W104 | 38,192,410 | 5,903,000 | SH | SOLE | 5,903,000 | 0 | 0 | |||
| Soleno Therapeutics Inc | Common | 834203309 | 9,873,553 | 294,909 | SH | SOLE | 294,909 | 0 | 0 | |||
| Surrozen Inc | Common | 86889P208 | 7,573,800 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | |||
| Tango Therapeutics Inc | Common | 87583X109 | 45,077,998 | 2,154,780 | SH | SOLE | 2,154,780 | 0 | 0 | |||
| Tenax Therapeutics Inc | Common | 88032L605 | 3,331,245 | 208,333 | SH | SOLE | 208,333 | 0 | 0 | |||
| Terns Pharmaceuticals Inc | Common | 880881107 | 70,350,517 | 1,334,418 | SH | SOLE | 1,334,418 | 0 | 0 | |||
| Trevi Therapeutics Inc | Common | 89532M101 | 60,779,389 | 5,094,668 | SH | SOLE | 5,094,668 | 0 | 0 | |||
| Unicycive Therapeutics | Common | 90466Y202 | 11,777,647 | 1,789,916 | SH | SOLE | 1,789,916 | 0 | 0 | |||
| Veradermics Inc | Common | 922967104 | 18,945,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| Viridian Therapeutics Inc | Common | 92790C104 | 3,252,593 | 166,288 | SH | SOLE | 166,288 | 0 | 0 | |||